Tiredness News and Research

RSS

A similarity in the meaning of sleep quality between insomniacs, normal sleepers

Both insomnia patients and normal sleepers define sleep quality by tiredness upon waking and throughout the day, feeling rested and restored upon waking, and the number of awakenings they experienced in the night.

3 Mar 2008

Takeda submits NDA for Alogliptin (SYR-322) in the U.S.

Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.

7 Jan 2008

A happy marriage eases a working woman's stress

According to new gender research, a happy marriage is more likely to reduce a working woman's stress levels than her husband's.

2 Jan 2008

U.S. health officials search for air travellers exposed to drug-resistant TB

Health officials in the United States are again trying to track down dozens of airline passengers who may have been inadvertently exposed to tuberculosis (TB).

2 Jan 2008

GlaxoSmithKline response to JAMA article on ICES retrospective analysis

The following is GlaxoSmithKline's response to the retrospective analysis by the Institute for Clinical Evaluative Sciences (ICES) titled "Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes".

13 Dec 2007

GlaxoSmithKline implements changes to the US product label for Avandia

GlaxoSmithKline announced today that it is implementing changes to the US product label for Avandia(R) (rosiglitazone maleate), based on an extensive and thorough review by the FDA of myocardial ischemia data on Avandia, the most widely studied oral anti-diabetic medicine available.

15 Nov 2007

TB man forcibly detained in British hospital

A man is being detained in a hospital in Manchester, England in order to prevent him spreading tuberculosis (TB) to other people.

10 Oct 2007

Colonoscopy most effective screening option for colon cancer

According to the American Society for Gastrointestinal Endoscopy (ASGE), colonoscopy remains the most effective screening option for colorectal cancer.

3 Oct 2007

Dying for a good night's sleep?

If you are one of those who toss and turn every night trying to get a good night's sleep the latest research from Britain will not make you feel any better.

24 Sep 2007

ACTOS associated with reduced risk of heart attack and stroke in patients with type 2 diabetes

Results presented at the 43rd Annual Meeting of the European Association for the Study of Diabetes demonstrate the ability of ACTOS (pioglitazone HCl) to reduce the risk of ischemic cardiovascular disease in patients with type 2 diabetes.

20 Sep 2007

Cell phone use after bedtime is prevalent among adolescents - contributes to poor sleep

The use of modern means of interpersonal and mass communication has become an essential part of being young. Technology has enabled two people to connect with each other virtually anywhere and at any time, a privilege that, according to new research, is often abused by youngsters and cutting into their sleep time.

3 Sep 2007

Legionnaires' disease in Surrey with links to Institute of Animal Health at Pirbright

The Health Protection Agency can confirm that its Surrey Health Protection Unit is involved in an investigation with the Health and Safety Executive and local environmental health officers of a reported case of Legionnaires' disease with alleged links to the Institute of Animal Health at Pirbright, in Surrey .

12 Aug 2007

Functional food research

As consumers around the globe increasingly keep attuned to the effects diet can have on their health, researchers are now eyeing innovations in functional foods that could address disease prevention as well as maintain a fit lifestyle.

1 Aug 2007

Takeda responds to FDA recommendation on Actos

Following a joint meeting today of the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development (TGRD) underscores its position that ACTOS(R) (pioglitazone HCl) offers a proven safety profile regarding the risk of cardiovascular disease.

30 Jul 2007

Study to evaluate lithium for the treatment of bipolar disorder

Researchers at the University of Illinois at Chicago are participating in a national study to evaluate lithium for the treatment of bipolar disorder in children and adolescents.

18 Jul 2007

Post-holiday syndrome

Millions of people will leave their working places and start their holidays in the next weeks.

20 Jun 2007

Treating sub clinical hypothyroidism

Putting on weight and feeling lethargic? Then new research from Newcastle University and funded by Gateshead NHS Foundation Trust shows it is worth having your thyroid levels checked, as these can be symptoms of thyroid disease which is easily identified and treated.

30 May 2007

FDA completes review of FluMist

MedImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has stated the agency has completed its review of all submissions made related to the supplemental biologics license application (sBLA) to extend the age indication of FluMist (Influenza Virus Vaccine Live, Intranasal).

28 May 2007

FluMist may help reduce the burden of seasonal influenza

MedImmune, Inc. has announced research results showing that use of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) in daycare and school settings may help reduce the burden of seasonal influenza.

9 May 2007

Study of fatigue in cancer patients

Fatigue is one of the most common and distressing symptoms cancer patients experience during chemotherapy and radiation treatment, but it's difficult for health care professionals to accurately assess its severity.

4 May 2007